Search

Author/Creator Hilfrich, J.

1. Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29). (September 2016)

Authors:
von Minckwitz, G.; Rezai, M.; Tesch, H.; Huober, J.; Gerber, B.; Zahm, D.M.; Hilfrich, J.; Costa, S.D.; Dubsky, P.; Blohmer, J.U.; Denkert, C.; Hanusch, C.; Jackisch, C.; Kümmel, S.; Fasching, P.A.; Schneeweiss, A.; Paepke, S.; Untch, M.; Burchardi, N.; Mehta, K.
Journal:
European journal of cancer
Issue:
Volume 64(2016)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search